drugset
drugset / Trial / NCT03460756

A Clinical Trial of Oral Ganaxolone in Women With Postpartum Depression

NCT03460756 ↗

Phase 2 Completed 84 enrolled Marinus Pharmaceuticals
RandomizedParallel-groupQuadruple-blindTreatment

Summary

A clinical study to evaluate safety, tolerability and efficacy of oral administration of ganaxolone in women with postpartum depression

Timeline

Start
2017-12-28
Primary completion
2019-07-05
Completion
2019-07-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Ganaxolone Small molecule — Oral

Indications

developmental delay, impaired speech, and behavioral abnormalities postpartum depression pregnancy disorder puerperal disorder